IGF-1R Modulation of Acute GH-Induced STAT5 Signaling: Role of Protein Tyrosine Phosphatase Activity

Published on Sep 12, 2013in Molecular Endocrinology3.628
· DOI :10.1210/ME.2013-1178
Yujun Gan6
Estimated H-index: 6
(UAB: University of Alabama at Birmingham),
Yue Zhang15
Estimated H-index: 15
(UAB: University of Alabama at Birmingham)
+ 7 AuthorsStuart J. Frank45
Estimated H-index: 45
(UAB: University of Alabama at Birmingham)
GH is a potent anabolic and metabolic factor that binds its cell surface receptor (GHR), activating the GHR-associated tyrosine kinase, Janus kinase 2, which phosphorylates and activates the latent transcription factor, signal transducer and activator of transcription 5 (STAT5). Some GH actions are mediated by the elaboration of IGF-1, which exerts effects by binding and activating the heterotetrameric tyrosine kinase growth factor receptor, IGF-1R. In addition to this GH-GHR-IGF-1-IGF-1R scheme, we have demonstrated in primary osteoblasts and in islet β-cells that then deletion or silencing of IGF-1R results in diminished GH-induced STAT5 phosphorylation, suggesting that the presence of IGF-1R may facilitate GH signaling. In this study, we explore potential roles for protein tyrosine phosphatase activity in modulating GH-induced signaling, comparing conditions in which IGF-1R is present or diminished. We confirm that in mouse primary osteoblasts harboring loxP sites flanking the IGF-1R gene, infection with an adenovirus that expresses the Cre recombinase results in IGF-1R deletion and diminished acute GH-induced STAT5 phosphorylation. Furthermore, we present a new model of IGF-1R silencing, in which expression of short hairpin RNA directed at IGF-1R greatly reduces IGF-1R abundance in LNCaP human prostate cancer cells. In both models, treatment with a chemical inhibitor of protein tyrosine phosphatase-1B (PTP-1B), but not one of src homology region 2 domain-containing phosphotase-1 (SHP-1) and SHP-2, reverses the loss of GH-induced STAT5 phosphorylation in cells lacking IGF-1R but has no effect in cells with intact IGF-1R. Furthermore, expression of either a dominant-negative PTP-1B or the PTP-1B-interacting inhibitory protein, constitutive photomorphogenesis 1, also rescues acute GH-induced STAT5 signaling in IGF-1R-deficient cells but has no effect in IGF-1R replete cells. By expressing a substrate-trapping mutant PTP-1B, we demonstrate that tyrosine phosphorylated Janus kinase-2 is a PTP-1B substrate only in cells lacking IGF-1R. Collectively, our data suggest that IGF-1R positively regulates acute GH signaling by preventing access of PTP-1B activity to Janus kinase 2 and thereby preventing PTP-1B-mediated suppression of GH-induced STAT5 activation.
  • References (54)
  • Citations (14)
📖 Papers frequently viewed together
512 Citations
24 Citations
25 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Ahmed Bettaieb (UC Davis: University of California, Davis)H-Index: 27
#2Jesse Bakke (UC Davis: University of California, Davis)H-Index: 8
Last. Fawaz G. Haj (UC Davis: University of California, Davis)H-Index: 35
view all 18 authors...
Protein-tyrosine phosphatase 1B (PTP1B) is a physiological regulator of glucose homeostasis and adiposity and is a drug target for the treatment of obesity and diabetes. Here we identify pyruvate kinase M2 (PKM2) as a novel PTP1B substrate in adipocytes. PTP1B deficiency leads to increased PKM2 total tyrosine and Tyr105 phosphorylation in cultured adipocytes and in vivo. Substrate trapping and mutagenesis studies identify PKM2 Tyr-105 and Tyr-148 as key sites that mediate PTP1B-PKM2 interaction....
35 CitationsSource
#1Wenying Ren (Tufts Medical Center)H-Index: 4
#2Yingmin Sun (Tufts Medical Center)H-Index: 4
Last. Keyong Du (Tufts Medical Center)H-Index: 13
view all 4 authors...
Recent studies reveal that COP1 suppresses the expression of gluconeogenetic genes and prohibits hepatic glucose production. To get more insight into COP1 in hepatic cells, we examined the impact of COP1 on insulin-responsive genes and insulin signaling. We found that COP1 increased the responsiveness of insulin-modulated genes to insulin in that it promoted the expression of insulin-induced genes and inhibited that of insulin-suppressed genes and that COP1 enhanced insulin signaling as it promo...
4 CitationsSource
Type 1 interferons (IFN1) elicit antiviral defenses by activating the cognate receptor composed of IFN-α/β receptor chain 1 (IFNAR1) and IFNAR2. Down-regulation of this receptor occurs through IFN1-stimulated IFNAR1 ubiquitination, which exposes a Y466-based linear endocytic motif within IFNAR1 to recruitment of the adaptin protein-2 complex (AP2) and ensuing receptor endocytosis. Paradoxically, IFN1-induced Janus kinase-mediated phosphorylation of Y466 is expected to decrease its affinity for A...
26 CitationsSource
#1Jean-Christophe Marine (Katholieke Universiteit Leuven)H-Index: 52
This Review discusses the links between the E3 ubiquitin ligase COP1 and cancer, as shown by mouse models and human tumour data. It describes the evidence for COP1 targeting both oncoproteins and tumour suppressor proteins for degradation, how these apparently contradictory data might be rectified and the therapeutic implications.
58 CitationsSource
#1Audrey De Rocca Serra-Nédélec (French Institute of Health and Medical Research)H-Index: 2
#2Thomas EdouardH-Index: 15
Last. Armelle YartH-Index: 9
view all 14 authors...
Noonan syndrome (NS), a genetic disease caused in half of cases by activating mutations of the tyrosine phosphatase SHP2 (PTPN11), is characterized by congenital cardiopathies, facial dysmorphic features, and short stature. How mutated SHP2 induces growth retardation remains poorly understood. We report here that early postnatal growth delay is associated with low levels of insulin-like growth factor 1 (IGF-1) in a mouse model of NS expressing the D61G mutant of SHP2. Conversely, inhibition of S...
59 CitationsSource
#1Veena Sangwan (McGill University)H-Index: 27
#2Jasmine V. AbellaH-Index: 13
Last. Morag ParkH-Index: 63
view all 7 authors...
Abstract The endoplasmic reticulum-localized non-receptor protein-tyrosine phosphatase 1B (PTP1B) is associated with oncogenic, metabolic, and cytokine-related signaling and functionally targets multiple receptor tyrosine kinases (RTKs) for dephosphorylation. Loss of PTP1B activity leads to enhanced ligand-dependent biological activity of the Met RTK among others. Here, we demonstrate that knockdown of PTP1B or expression of a PTP1B trapping aspartic acid-to-alanine substitution (D/A) mutant del...
25 CitationsSource
#1Fanxin Ma (St. Joseph's Hospital and Medical Center)H-Index: 5
#2Zhe Wei (St. Joseph's Hospital and Medical Center)H-Index: 1
Last. Yao Huang (St. Joseph's Hospital and Medical Center)H-Index: 16
view all 8 authors...
Dysfunction and destruction of pancreatic islet β-cells is a hallmark of diabetes. Better understanding of cell signals regulating β-cell growth and antiapoptosis will allow development of therapeutic strategies for diabetes by preservation and expansion of β-cell mass. GH and IGF-I share a complicated physiological relationship and have both been implicated in β-cell function. GH and IGF-I exert their biological effects through binding to respective receptors (GHR and IGF-IR) and subsequently e...
24 CitationsSource
#1Jie Xu (UAB: University of Alabama at Birmingham)H-Index: 12
#2Yue Zhang (UAB: University of Alabama at Birmingham)H-Index: 15
Last. Stuart J. Frank (UAB: University of Alabama at Birmingham)H-Index: 45
view all 8 authors...
GH and PRL receptors associate in human breast cancer cells. This may modulate GH signaling and affect strategies of GH and PRL antagonism in cancer.
44 CitationsSource
#1Andrew J. Brooks (UQ: University of Queensland)H-Index: 29
#1Andrew J. Brooks (UQ: University of Queensland)H-Index: 19
Last. Michael J. Waters (UQ: University of Queensland)H-Index: 57
view all 2 authors...
Growth hormone is widely used clinically to promote growth and anabolism and for other purposes. Its actions are mediated via the growth hormone receptor, both directly by tyrosine kinase activation and indirectly by induction of insulin-like growth factor 1 (IGF-1). Insensitivity to growth hormone (Laron syndrome) can result from mutations in the growth hormone receptor and can be treated with IGF-1. This treatment is, however, not fully effective owing to the loss of the direct actions of grow...
185 CitationsSource
Normal mammary development requires coordinated interactions of numerous factors, including prolactin (PRL) and insulin-like growth factor I (IGF-I), both of which have also been implicated in breast cancer pathogenesis and progression. We previously reported that PRL and IGF-I synergize in breast cancer cells to activate ERK1/2 and AKT, leading to increased proliferation, survival, and invasion. Intriguingly, PRL co-treatment with IGF-I augments IGF-I receptor (IGF-IR) phosphorylation 2-fold hi...
17 CitationsSource
Cited By14
#1Daniel DiToro (UAB: University of Alabama at Birmingham)H-Index: 5
#2Stacey N. Harbour (UAB: University of Alabama at Birmingham)H-Index: 4
Last. Henrietta Turner (UAB: University of Alabama at Birmingham)H-Index: 9
view all 18 authors...
Appropriate balance of T helper 17 (Th17) and regulatory T (Treg) cells maintains immune tolerance and host defense. Disruption of Th17-Treg cell balance is implicated in a number of immune-mediated diseases, many of which display dysregulation of the insulin-like growth factor (IGF) system. Here, we show that, among effector T cell subsets, Th17 and Treg cells selectively expressed multiple components of the IGF system. Signaling through IGF receptor (IGF1R) activated the protein kinase B-mamma...
#1Joseph A.M.J.L. Janssen (EUR: Erasmus University Rotterdam)H-Index: 31
Insulin-like growth factor-I (IGF-I) and insulin-like growth factor-II (IGF-II) play a crucial factor in the growth, differentiation and survival of cells in health and disease. IGF-I and IGF-II primarily activate the IGF-I receptor (IGF-IR), which is present on the cell surface. Activation of the IGF-IR stimulates multiple pathways which finally results in multiple biological effects in a variety of tissues and cells. In addition, activation of the IGF-IR has been found to be essential for the ...
2 CitationsSource
#1Ashiya Buckels (UAB: University of Alabama at Birmingham)H-Index: 2
#2Yue Zhang (UAB: University of Alabama at Birmingham)H-Index: 15
Last. Stuart J. Frank (UAB: University of Alabama at Birmingham)H-Index: 45
view all 7 authors...
Abstract Melanoma is the most aggressive skin cancer. Its aggressiveness is most commonly attributed to ERK pathway mutations leading to constitutive signaling. Though initial tumor regression results from targeting this pathway, resistance often emerges. Interestingly, interrogation of the NCI-60 database indicates high growth hormone receptor (GHR) expression in melanoma cell lines. To further characterize melanoma, we tested responsiveness to human growth hormone (GH). GH treatment resulted i...
1 CitationsSource
#1Yue Zhang (UAB: University of Alabama at Birmingham)H-Index: 15
#2Sajina Gc (UAB: University of Alabama at Birmingham)H-Index: 1
Last. Stuart J. Frank (UAB: University of Alabama at Birmingham)H-Index: 45
view all 8 authors...
Abstract Human growth hormone (GH) binds and activates GH receptor (GHR) and prolactin (PRL) receptor (PRLR). LNCaP human prostate cancer cells express only GHR. A soluble fragment of IGF-1 receptor (IGF-1R) extracellular domain (sol IGF-1R) interacts with GHR and blocks GH signaling. We now explore sol IGF-1R's specificity for inhibiting GH signaling via GHR vs. PRLR and test GHR and PRLR extracellular domain inhibition determinants. Although T47D human breast cancer cells express GHR and PRLR,...
1 CitationsSource
#1Caroline E. Nunes-Xavier (Oslo University Hospital)H-Index: 10
#2Janire MingoH-Index: 5
Last. Rafael Pulido (Ikerbasque)H-Index: 11
view all 4 authors...
Abstract Prostate cancer (PCa) is the most frequent malignancy in the male population of Western countries. Although earlier detection and more active surveillance have improved survival, it is still a challenge how to treat advanced cases. Since androgen receptor (AR) and AR-related signaling pathways are fundamental in the growth of normal and neoplastic prostate cells, targeting androgen synthesis or AR activity constitutes the basis of the current hormonal therapies in PCa. However, resistan...
3 CitationsSource
#1Gherardo MazziottiH-Index: 42
#2Stefano Frara (UniSR: Vita-Salute San Raffaele University)H-Index: 10
Last. Andrea Giustina (UniSR: Vita-Salute San Raffaele University)H-Index: 64
view all 3 authors...
: Neuroendocrinology of bone is a new area of research based on the evidence that pituitary hormones may directly modulate bone remodeling and metabolism. Skeletal fragility associated with high risk of fractures is a common complication of several pituitary diseases such as hypopituitarism, Cushing disease, acromegaly, and hyperprolactinemia. As in other forms of secondary osteoporosis, pituitary diseases generally affect bone quality more than bone quantity, and fractures may occur even in the...
29 CitationsSource
#1Farhad Dehkhoda (UQ: University of Queensland)H-Index: 1
#2Christine Lee (UQ: University of Queensland)H-Index: 2
Last. Andrew J. Brooks (UQ: University of Queensland)H-Index: 29
view all 4 authors...
The growth hormone receptor (GHR), although most well known for regulating growth, has many other important biological functions including regulating metabolism and controlling physiological processes related to the hepatobiliary, cardiovascular, renal, gastrointestinal, and reproductive systems. In addition, growth hormone signaling is an important regulator of aging and plays a significant role in cancer development. Growth hormone activates the Janus kinase (JAK)-signal transducer and activat...
27 CitationsSource
#1Shuang Wang (Dalian Medical University)H-Index: 2
#2Jin Wu (Dalian Medical University)H-Index: 1
Last. Yingjie Wu (Dalian Medical University)H-Index: 1
view all 5 authors...
Abstract Growth hormone (GH) exerts numerous effects on tissues through binding to its receptor, GHR, which resides on cell membranes in many different organs and tissues. Endocrine pancreatic β cells are the only source of insulin secretion in response to metabolic demand, thereby regulating blood glucose and maintaining metabolic homeostasis. β cell dysfunction is the main composition of diabetes mellitus. Numerous studies have provided strong evidence that GHR signaling plays an independent r...
3 CitationsSource
#1Heather E. Bergan-Roller (NU: University of Nebraska–Lincoln)H-Index: 3
#2Mark A. Sheridan (TTU: Texas Tech University)H-Index: 32
Abstract Although growth hormone (GH) is a multifunctional factor that coordinates various aspects of feeding, reproduction, osmoregulation, and immune system function, perhaps two of its most studied actions are the regulation of growth and metabolism, particularly lipid metabolism. In this review, we describe the major growth-promoting and lipid metabolic actions of GH and then discuss how the GH system regulates these actions. Numerous intrinsic and extrinsic factors provide information about...
38 CitationsSource
#1Heather E. Bergan-Roller (NDSU: North Dakota State University)H-Index: 1
#2Alicia T. Ickstadt (NDSU: North Dakota State University)H-Index: 2
Last. Mark A. Sheridan (NDSU: North Dakota State University)H-Index: 32
view all 4 authors...
Abstract Growth hormone (GH) has many actions in vertebrates, including the regulation of two disparate metabolic processes: growth promotion (anabolic) and the mobilization of stored lipids (catabolic). Our previous studies showed that GH stimulated IGF-1 production in hepatocytes from fed rainbow trout, but in cells from fasted fish GH stimulated lipolysis. In this study, we used rainbow trout ( Oncorhynchus mykiss ) to elucidate regulation of the mechanisms that enable cells to alter their li...
5 CitationsSource